```html

Yellow Tendonitis

What is Yellow Tendonitis?

Yellow tendonitis, also called xanthomatous tendinopathy or “yellow‑deposit tendonitis,” is a condition in which yellow‑colored, cholesterol‑rich deposits (xanthomas) accumulate within a tendon, causing inflammation, thickening, and pain. The most frequently affected tendon is the Achilles, but the patellar, quadriceps, and hand‑extensor tendons can also be involved. The discoloration is not a sign of infection; rather, it reflects the buildup of lipid‑laden macrophages (foam cells) in the tendon’s extracellular matrix.

While the term “yellow tendonitis” is not commonly used in mainstream orthopedic literature, it is often described in dermatology and metabolic disease references because the underlying problem is usually a systemic lipid disorder. Recognizing the condition is important because it can be a visible clue to an otherwise silent lipid‑metabolism abnormality that raises the risk of cardiovascular disease.

Common Causes

Yellow deposits in tendons are most often secondary to metabolic disturbances, but trauma and medication can also play a role. The main contributors include:

• Familial hypercholesterolemia (FH): An inherited defect in LDL‑receptor function leads to high LDL‑cholesterol and tendon xanthomas in up to 30 % of patients.
• Primary biliary cholangitis (PBC) and other cholestatic liver diseases: Elevated cholesterol and bile acids promote foam‑cell formation.
• Familial combined hyperlipidemia: Elevated LDL‑C and triglycerides jointly increase xanthoma risk.
• Type III hyperlipoproteinemia (dysbetalipoproteinemia): ApoE2/E2 genotype predisposes to lipid‐laden macrophage infiltration of tendons.
• Statin‑induced tendon changes: Rarely, long‑term high‑dose statins can cause tendon inflammation and yellowish discoloration.
• Repeated mechanical stress or micro‑trauma: Overuse of a tendon can attract inflammatory cells that later become xanthomatous.
• Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus): Chronic inflammation may accelerate lipid deposition in connective tissue.
• Medications that alter lipid metabolism: Corticosteroids, cyclosporine, and some antiretrovirals can raise serum lipids.
• Obesity and metabolic syndrome: High triglycerides and low‑grade inflammation increase the chance of tendon xanthomas.
• Smoking: Impairs tendon healing and is associated with higher prevalence of xanthomatous changes.

Associated Symptoms

Yellow tendonitis rarely occurs in isolation. Patients often report a combination of the following:

• Localized pain that worsens with activity and improves with rest.
• Visible or palpable yellow‑ish thickening of the tendon, especially over the Achilles or patellar region.
• Stiffness or reduced range of motion in the affected joint.
• Swelling that may feel firm rather than fluid‑filled.
• Occasional clicking or “crepitus” when the tendon moves.
• Systemic signs of hyperlipidemia such as xanthelasma (yellow plaques around the eyes) or eruptive xanthomas on the skin.
• Fatigue or generalized achiness if an underlying inflammatory disease is present.

When to See a Doctor

Prompt medical evaluation is recommended if any of the following occur:

• Sudden, severe pain that does not improve with rest, ice, or over‑the‑counter pain relievers.
• Rapid increase in tendon size or a feeling of tearing.
• Difficulty bearing weight on the affected limb (e.g., unable to walk on tiptoes with an Achilles problem).
• Redness, warmth, or fever suggesting infection (septic tenosynovitis).
• Newly discovered yellow deposits accompanied by a family history of early heart attacks or strokes.
• Any sign of nerve compression, such as numbness, tingling, or weakness in the foot or hand.

Because yellow tendonitis can be a marker for cardiovascular disease, a full lipid panel and cardiovascular risk assessment are advised even when pain is mild.

Diagnosis

Diagnosing yellow tendonitis involves a combination of clinical examination, imaging, and laboratory tests.

Clinical Examination

• Inspection for yellow discoloration, nodules, or thickening.
• Palpation to assess tenderness, firmness, and mobility of the tendon.
• Range‑of‑motion testing to identify functional limitation.

Imaging Studies

• Ultrasound: First‑line, inexpensive, and can show increased tendon thickness and hyperechoic deposits.
• MRI: Provides detailed soft‑tissue contrast; typical findings include low‑signal xanthomatous areas within the tendon and surrounding inflammation.
• X‑ray: May reveal calcified deposits if chronic, but not useful for early yellow tendonitis.

Laboratory Tests

• Fasting lipid panel (LDL‑C, HDL‑C, triglycerides, total cholesterol).
• Genetic testing for familial hypercholesterolemia (LDLR, APOB, PCSK9 mutations) if family history is suggestive.
• Inflammatory markers (CRP, ESR) when an autoimmune disease is suspected.
• Liver function tests if cholestatic disease is a consideration.

Biopsy (Rare)

In atypical cases, a tendon biopsy may be performed to confirm xanthomatous infiltration and rule out other conditions such as gouty tophi or tumorous lesions.

Treatment Options

Treatment is aimed at three goals: relieve pain, reduce tendon inflammation, and address the underlying metabolic cause.

Conservative (Home) Management

• Rest and activity modification: Avoid high‑impact or repetitive loading of the affected tendon for 2–4 weeks.
• Ice therapy: 15–20 minutes every 2–3 hours during acute exacerbations.
• Compression and elevation: Particularly useful for lower‑extremity tendons.
• Gentle stretching and eccentric strengthening: Programs such as the Alfredson protocol for Achilles tendonitis have shown benefit once pain subsides.
• Topical NSAIDs or OTC oral NSAIDs (ibuprofen, naproxen): Use as directed, considering GI and renal safety.
• Footwear adjustments: Heel lifts, orthotics, or cushioned shoes can off‑load the Achilles.

Medical Therapies

• Lipid‑lowering agents: Statins are first‑line for most hypercholesterolemia; PCSK9 inhibitors (evolocumab, alirocumab) are options for statin‑intolerant or severe FH patients.
• Ezetimibe or bile‑acid sequestrants: Useful adjuncts to achieve LDL‑C targets <70 mg/dL for high‑risk individuals.
• Corticosteroid injections: May reduce local inflammation but can weaken tendon fibers; reserved for short‑term use.
• Systemic anti‑inflammatory agents: In cases linked to rheumatoid arthritis or lupus, disease‑modifying drugs (methotrexate, biologics) help control both joint and tendon disease.
• Physical‑therapy‑guided modalities: Ultrasound therapy, laser therapy, or shockwave therapy can improve vascularity and reduce pain.

Surgical Options

Surgery is considered when:

• Persistent pain limits daily activities after 6‑12 months of optimal conservative care.
• There is a large, firm xanthomatous mass causing mechanical impingement.
• Tendon rupture risk is high (e.g., severe thinning seen on MRI).

Procedures range from limited debridement of xanthomatous tissue to complete tendon reconstruction with grafts. Post‑operative rehabilitation is essential for functional recovery.

Prevention Tips

Because many cases stem from systemic lipid abnormalities, prevention focuses on lifestyle and medical management:

• Maintain a heart‑healthy diet: Emphasize fruits, vegetables, whole grains, lean protein, and limit saturated fats and trans‑fatty acids.
• Regular aerobic exercise: At least 150 minutes of moderate‑intensity activity per week improves lipid profiles and tendon health.
• Achieve and maintain a healthy weight: Reduces mechanical load on tendons and improves metabolic parameters.
• Quit smoking: Smoking impairs collagen synthesis and worsens lipid metabolism.
• Routine lipid screening: Adults >20 years should have a fasting lipid panel every 4–6 years; earlier if family history is positive.
• Adhere to prescribed lipid‑lowering therapy: Never stop statins without physician guidance.
• Gradual progression of training: When starting a new sport or fitness program, increase load by no more than 10 % per week to avoid overuse.
• Protective footwear: Use appropriate shoes for activities that stress the Achilles or patellar tendons.

Emergency Warning Signs

Key Take‑aways

Yellow tendonitis is a visible manifestation of lipid‑related tendon inflammation. While it can cause localized discomfort, its greatest clinical importance lies in flagging underlying dyslipidemia, which carries a high risk for cardiovascular disease. Early recognition, comprehensive lipid management, and appropriate tendon‑care strategies can alleviate symptoms, protect tendon integrity, and reduce long‑term heart‑related complications.

References:

• Mayo Clinic. “Tendinitis.” Updated 2023. mayoclinic.org
• National Heart, Lung, and Blood Institute. “Familial Hypercholesterolemia.” 2022. nhlbi.nih.gov
• Cleveland Clinic. “Xanthomas and Tendon Involvement.” 2021. clevelandclinic.org
• American College of Rheumatology. “Tendon Disorders.” 2023. rheumatology.org
• World Health Organization. “Guidelines for the Management of Dyslipidaemias.” 2022. who.int

```